FI913035A0 - Ny terapeutiskt aktiv foerening och foerfarande foer dess framstaellning. - Google Patents

Ny terapeutiskt aktiv foerening och foerfarande foer dess framstaellning.

Info

Publication number
FI913035A0
FI913035A0 FI913035A FI913035A FI913035A0 FI 913035 A0 FI913035 A0 FI 913035A0 FI 913035 A FI913035 A FI 913035A FI 913035 A FI913035 A FI 913035A FI 913035 A0 FI913035 A0 FI 913035A0
Authority
FI
Finland
Prior art keywords
foerening
terapeutiskt
aktiv
foerfarande foer
och foerfarande
Prior art date
Application number
FI913035A
Other languages
English (en)
Finnish (fi)
Inventor
Arne Elof Braendstroem
Per Lennart Lindberg
Gunnel Elisabeth Sunden
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of FI913035A0 publication Critical patent/FI913035A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI913035A 1988-12-22 1991-06-20 Ny terapeutiskt aktiv foerening och foerfarande foer dess framstaellning. FI913035A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19888804629A SE8804629D0 (sv) 1988-12-22 1988-12-22 New therapeutically active compounds
PCT/SE1989/000740 WO1990006925A1 (en) 1988-12-22 1989-12-20 New therapeutically active compound and a process for its preparation

Publications (1)

Publication Number Publication Date
FI913035A0 true FI913035A0 (fi) 1991-06-20

Family

ID=20374310

Family Applications (2)

Application Number Title Priority Date Filing Date
FI913035A FI913035A0 (fi) 1988-12-22 1991-06-20 Ny terapeutiskt aktiv foerening och foerfarande foer dess framstaellning.
FI954768A FI954768A (fi) 1988-12-22 1995-10-06 Välituotteina käyttökelpoiset 4-syklopropyylimetoksipyridiiniyhdisteet

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI954768A FI954768A (fi) 1988-12-22 1995-10-06 Välituotteina käyttökelpoiset 4-syklopropyylimetoksipyridiiniyhdisteet

Country Status (32)

Country Link
US (2) US5008278A (zh)
EP (1) EP0449940B1 (zh)
JP (1) JP2793906B2 (zh)
KR (1) KR910700249A (zh)
CN (1) CN1028231C (zh)
AR (1) AR248136A1 (zh)
AT (1) ATE127799T1 (zh)
AU (1) AU634741B2 (zh)
BG (1) BG60102B2 (zh)
CA (1) CA2005986C (zh)
DD (2) DD296078A5 (zh)
DE (1) DE68924273T2 (zh)
DK (1) DK170800B1 (zh)
EG (1) EG19303A (zh)
FI (2) FI913035A0 (zh)
GR (1) GR1002252B (zh)
HR (1) HRP920831A2 (zh)
HU (2) HU205927B (zh)
IE (1) IE894048L (zh)
IL (1) IL92798A0 (zh)
LT (2) LT3914B (zh)
LV (1) LV10187B (zh)
NZ (1) NZ231872A (zh)
PH (1) PH27400A (zh)
PL (1) PL161150B1 (zh)
PT (1) PT92648B (zh)
RO (1) RO110494B1 (zh)
RU (2) RU2073676C1 (zh)
SE (1) SE8804629D0 (zh)
WO (1) WO1990006925A1 (zh)
YU (1) YU46806B (zh)
ZA (2) ZA899795B (zh)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ244301A (en) * 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
TNSN95063A1 (fr) * 1994-05-27 1996-02-06 Astra Ab Nouveaux benzimidazoles substitues
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
ATE414509T1 (de) * 1994-07-08 2008-12-15 Astrazeneca Ab Aus vielen einzeleinheiten zusammengesetzte tablettierte dosisform
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
DE19758573C2 (de) * 1997-11-26 2001-03-01 Implex Hear Tech Ag Fixationselement für ein implantierbares Mikrofon
KR100627614B1 (ko) * 1998-04-20 2006-09-25 에자이 가부시키가이샤 안정화된 벤즈이미다졸계 화합물 함유 조성물로 이루어지는 의약제제
TWI243672B (en) 1999-06-01 2005-11-21 Astrazeneca Ab New use of compounds as antibacterial agents
ATE369857T1 (de) 1999-10-20 2007-09-15 Eisai R&D Man Co Ltd Methode zur stabilisierung von benzimidazol- verbindungen
SE0000774D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
US20040006111A1 (en) * 2002-01-25 2004-01-08 Kenneth Widder Transmucosal delivery of proton pump inhibitors
CA2480358A1 (en) * 2002-03-26 2003-10-09 Dr. Reddy's Laboratories Limited Crystalline forms of rabeprazole sodium
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
US20040248942A1 (en) * 2003-02-20 2004-12-09 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
WO2005007115A2 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
US20050031700A1 (en) * 2003-07-18 2005-02-10 Sanatarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1708684A2 (en) 2003-09-26 2006-10-11 Alza Corporation Drug coating providing high drug loading and methods for providing the same
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
CA2658804A1 (en) 2006-07-25 2008-01-31 Vecta Ltd. Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with ppi
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
CA2736547C (en) 2008-09-09 2016-11-01 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
AU2010263304A1 (en) 2009-06-25 2012-02-02 Astrazeneca Ab Method for treating a patient at risk for developing an NSAID-associated ulcer
WO2011080500A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2519229A2 (en) 2009-12-29 2012-11-07 Novartis AG New pharmaceutical dosage form for the treatment of gastric acid-related disorders
WO2011080502A2 (en) 2009-12-29 2011-07-07 Orexo Ab New pharmaceutical dosage form for the treatment of gastric acid-related disorders
EP2601947A1 (en) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases
UA115139C2 (uk) 2011-12-28 2017-09-25 Поузен Інк. Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US428098A (en) 1890-05-20 Electric railway
US727150A (en) 1902-06-18 1903-05-05 Peter Paul Keller Adjustable hanger for incandescent lamps.
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (zh) * 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
DE3215503A1 (de) 1982-04-26 1983-11-03 Zängl GmbH, 8000 München Elektrisch beheiztes schneidgeraet
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
HU195220B (en) * 1983-05-03 1988-04-28 Byk Gulden Lomberg Chem Fqb Process for production of new fluor-alkoxi-benzimidasole-derivatives and medical compositions containig them
JPS6150979A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
US4738975A (en) * 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
JPS6261978A (ja) * 1985-09-12 1987-03-18 Otsuka Pharmaceut Co Ltd ５−フルオロ−１ｈ−ベンズイミダゾ−ル誘導体
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
JPS62201884A (ja) * 1986-02-28 1987-09-05 Tokyo Tanabe Co Ltd ベンズイミダゾール誘導体及びその製造法
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
NZ222495A (en) * 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
FI96860C (fi) * 1987-06-17 1996-09-10 Eisai Co Ltd Analogiamenetelmä lääkeaineena käytettävän pyridiinijohdannaisen valmistamiseksi
DE3722810A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung
DK171989B1 (da) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
JPH0676323B2 (ja) * 1987-08-28 1994-09-28 東京田辺製薬株式会社 抗潰瘍剤

Also Published As

Publication number Publication date
CA2005986A1 (en) 1990-06-22
WO1990006925A1 (en) 1990-06-28
LV10187B (en) 1995-04-20
ZA899795B (en) 1990-08-29
AU634741B2 (en) 1993-03-04
ATE127799T1 (de) 1995-09-15
IE894048L (en) 1990-06-22
FI954768A0 (fi) 1995-10-06
RU2073676C1 (ru) 1997-02-20
DD296079A5 (de) 1991-11-21
DE68924273D1 (de) 1995-10-19
PL161150B1 (en) 1993-05-31
JPH04502461A (ja) 1992-05-07
PT92648A (pt) 1990-06-29
US5008278A (en) 1991-04-16
CA2005986C (en) 1999-08-03
RU2042673C1 (ru) 1995-08-27
DK122291A (da) 1991-06-24
GR1002252B (en) 1996-04-23
BG60102B2 (bg) 1993-10-29
SE8804629D0 (sv) 1988-12-22
DK122291D0 (da) 1991-06-21
YU242689A (en) 1991-04-30
KR910700249A (ko) 1991-03-14
DK170800B1 (da) 1996-01-22
HU205927B (en) 1992-07-28
HRP920831A2 (en) 1995-12-31
DE68924273T2 (de) 1996-02-15
CN1028231C (zh) 1995-04-19
RO110494B1 (ro) 1996-01-30
EG19303A (en) 1994-11-30
HU901084D0 (en) 1991-09-30
ZA899794B (en) 1990-08-29
LT3980B (en) 1996-06-25
LTIP1726A (en) 1995-07-25
US5039808A (en) 1991-08-13
GR890100838A (el) 1991-03-15
CN1043713A (zh) 1990-07-11
DD296078A5 (de) 1991-11-21
NZ231872A (en) 1992-03-26
HU205926B (en) 1992-07-28
IL92798A0 (en) 1990-09-17
LV10187A (lv) 1994-10-20
JP2793906B2 (ja) 1998-09-03
HUT57202A (en) 1991-11-28
PT92648B (pt) 1995-09-12
PH27400A (en) 1993-06-21
YU46806B (sh) 1994-06-10
LTIP1721A (en) 1995-07-25
FI954768A (fi) 1995-10-06
AR248136A1 (es) 1995-06-30
LT3914B (en) 1996-04-25
EP0449940A1 (en) 1991-10-09
AU4817590A (en) 1990-07-10
EP0449940B1 (en) 1995-09-13

Similar Documents

Publication Publication Date Title
FI913035A0 (fi) Ny terapeutiskt aktiv foerening och foerfarande foer dess framstaellning.
FI891593A0 (fi) Antiinflammatorisk hudvaordskomposition och foerfarande foer dess framstaellning.
FI900158A0 (fi) Foerseglad slutare och foerfarande foer dess framstaellning.
FI891591A (fi) Hudvaordskomposition och foerfarande foer dess framstaellning.
FI896080A0 (fi) Omslag foer tobaksprodukt och foerfarande foer dess framstaellning.
FI896079A0 (fi) Omslag foer tobaksprodukt och foerfarande foer dess framstaellning.
FI903769A0 (fi) Sammanfogande kaernspik med varierande vaeggtjocklek och foerfarande foer dess framstaellning.
FI881424A (fi) Tryckalster saekerstaellt med varningsfigur och foerfarande foer dess utarbetning.
FI892206A0 (fi) Olja-i-vatten-vaextskyddsemulsion och foerfarande foer dess anvaendning.
FI892549A0 (fi) Stoetabsorberande omslagsmaterial och foerfarande foer dess framstaellning.
FI894380A (fi) Foerbaettrad slipbar belaeggning och foerfarande foer dess framstaellning.
FI900693A0 (fi) Ny substituerad-acetamid-foerening och foerfarande foer dess framstaellning.
FI904020A0 (fi) Doserarbehaollare foer klaedtvaettmedel och dess upptagning och avgivning.
FI880042A (fi) Fartyg och dess lastnings- och lossningssystem.
FI894334A (fi) Ny elektrolyscell och elektrolysenhet foer dess anvaendning.
FI895020A0 (fi) Foerbaettrad energifrigivande katalyt och dess anvaendning.
FI893131A0 (fi) Oktapeptid bunden vid sialsyra och dess framstaellning.
FI892958A0 (fi) Halvledaranordning foer en integrerad krets och foerfarande foer dess tillverkning.
FI895924A0 (fi) Stabilt flytande enzymkoncentrat och foerfarande foer dess framstaellning.
FI891330A (fi) Kompaktlysroer och foerfarande foer dess framstaellning.
FI904021A0 (fi) Doserarbehaollare foer klaedtvaettmedel och dess upptagning och avgivning.
FI880783A0 (fi) Balkartat byggnadselement och foerfarande foer dess framstaellning.
FI881884A0 (fi) Ny gravurna och foerfarande foer dess framstaellning.
FI885963A (fi) Baogram foer byggnad och foerfarande foer dess uppresning.
FI880508A0 (fi) Elektrisk installationsdosa och foerfarande foer dess framstaellning.

Legal Events

Date Code Title Description
FD Application lapsed